Below is Scrip’s monthly roundup, including information from Strategic Transactions, of recent technology transfer agreements between companies and academic or other research institutions.
Amicus Therapeutics Inc. is teaming up with the University of Pennsylvania to research and develop adeno-associated virus (AAV)...
Welcome to Scrip
Create an account to read this article
Already a subscriber?